Ep300/CREBBP-IN-8
Ep300/CREBBP-IN-8 (Example 37) is a potent and orally active Ep300 and CREBBP inhibitor with IC50s of 0.014 and 0.018 μM, respectively. Ep300/CREBBP-IN-8 can be used for the research of cancer[1].
Product Specifications
CAS Number
2259641-24-0
UNSPSC
12352005
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ep300-crebbp-in-8.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H]1N(C(C2(C3=CC=C(OC)C(F)=C3)CCCCC2)=O)C[C@H](F)C1)NC4=CC=C(NN=C5)C5=N4
Molecular Formula
C25H27F2N5O3
Molecular Weight
483.51
References & Citations
[1]NAITO Hiroyuki, et al. EP300 / CREBBP inhibitor. Patent JPWO2018235966A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CBP/p300
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-UNEL-H0385-01 5x 96 Tests
Uncoated Human RANκL (Receptor Activator of Nuclear Factor Kappa B Ligand) ELISA Kit
Sign In for Pricing
View Details E-UNEL-H0385-02 15x 96 Tests
Uncoated Human RANκL (Receptor Activator of Nuclear Factor Kappa B Ligand) ELISA Kit
Sign In for Pricing
View Details 